| scholarly article | Q13442814 |
| P356 | DOI | 10.1006/GENO.1996.4523 |
| P698 | PubMed publication ID | 9073509 |
| P2093 | author name string | M Ikeda | |
| J M Rommens | |||
| P J de Jong | |||
| C Lin | |||
| R Sherrington | |||
| C Wu | |||
| Y Liang | |||
| G Levesque | |||
| P E Fraser | |||
| P St George-Hyslop | |||
| W J Lukiw | |||
| E I Rogaev | |||
| K Holman | |||
| E A Rogaeva | |||
| P433 | issue | 3 | |
| P921 | main subject | Alzheimer's disease | Q11081 |
| alternative mRNA splicing, via spliceosome | Q21114084 | ||
| P304 | page(s) | 415-424 | |
| P577 | publication date | 1997-03-01 | |
| P1433 | published in | Genomics | Q5533503 |
| P1476 | title | Analysis of the 5' sequence, genomic structure, and alternative splicing of the presenilin-1 gene (PSEN1) associated with early onset Alzheimer disease | |
| P478 | volume | 40 |
| Q44313350 | 15d-PGJ2 and rosiglitazone suppress Janus kinase-STAT inflammatory signaling through induction of suppressor of cytokine signaling 1 (SOCS1) and SOCS3 in glia |
| Q48198154 | A novel presenilin-2 splice variant in human Alzheimer's disease brain tissue |
| Q40942783 | Aberrant splicing in the presenilin-1 intron 4 mutation causes presenile Alzheimer's disease by increased Abeta42 secretion. |
| Q49106027 | Absence of endoproteolysis but no effects on amyloid beta production by alternative splicing forms of presenilin-1, which lack exon 8 and replace D257A. |
| Q43511997 | Activated cAMP-response element-binding protein regulates neuronal expression of presenilin-1. |
| Q40688297 | Activation of transcription of the human presenilin 1 gene by 12-O-tetradecanoylphorbol 13-acetate |
| Q33556372 | Age-related vascular pathology in transgenic mice expressing presenilin 1-associated familial Alzheimer's disease mutations |
| Q48271780 | Alteration in brain presenilin-1 mRNA expression in sporadic Alzheimer's disease |
| Q48581384 | Alteration of transcription factors NF-κB and STAT1 in Alzheimer's disease brains |
| Q40488746 | Alternative initiation of transcription of the human presenilin 1 gene in SH-SY5Y and SK-N-SH cells. The role of Ets factors in the regulation of presenilin 1. |
| Q45104033 | Alternative splicing in the N-terminus of Alzheimer's presenilin 1. |
| Q54256368 | Alternative splicing isoforms in health and disease |
| Q42916132 | Alzheimer's disease amyloid beta converting left-handed Z-DNA back to right-handed B-form |
| Q36782581 | Alzheimer's disease and HIV associated dementia related genes: I. location and function |
| Q34208401 | Amyloid precursor protein (APP) and the biology of proteolytic processing: relevance to Alzheimer's disease |
| Q53229550 | Amyloid production and deposition in mutant amyloid precursor protein and presenilin-1 yeast artificial chromosome transgenic mice |
| Q38321732 | An upstream element containing an ETS binding site is crucial for transcription of the human presenilin-1 gene |
| Q33653958 | Biology of presenilins as causative molecules for Alzheimer disease. |
| Q40966106 | Calpain inhibitor I increases beta-amyloid peptide production by inhibiting the degradation of the substrate of gamma-secretase. Evidence that substrate availability limits beta-amyloid peptide production |
| Q41665591 | Cell and molecular neurobiology of presenilins: A role for the endoplasmic reticulum in the pathogenesis of Alzheimer's disease? |
| Q44193631 | Clinical and biomarker investigation of a patient with a novel presenilin-1 mutation (A431V) in the mild cognitive impairment stage of Alzheimer's disease |
| Q28280248 | Clinical phenotypic heterogeneity of Alzheimer's disease associated with mutations of the presenilin-1 gene |
| Q48038825 | Cloning of the cDNA encoding rat presenilin-2 |
| Q47820072 | Colivelin Ameliorates Impairments in Cognitive Behaviors and Synaptic Plasticity in APP/PS1 Transgenic Mice |
| Q37928936 | Conformational changes of non-B DNA. |
| Q48521070 | DNA methylation of Alzheimer disease and tauopathy-related genes in postmortem brain |
| Q33852318 | Dissociated phenotypes in presenilin transgenic mice define functionally distinct gamma-secretases |
| Q43838097 | Ectopic white matter neurons, a developmental abnormality that may be caused by the PSEN1 S169L mutation in a case of familial AD with myoclonus and seizures |
| Q48185246 | Effects of formalin fixation, paraffin embedding, and time of storage on DNA preservation in brain tissue: a BrainNet Europe study |
| Q51992642 | Exploring alternative transcript structure in the human genome using blocks and InterPro |
| Q44352378 | First evidence to show the topological change of DNA from B-dNA to Z-DNA conformation in the hippocampus of Alzheimer's brain |
| Q53262159 | Gene expression profiling in fetal, aged, and Alzheimer hippocampus: a continuum of stress-related signaling |
| Q34995070 | Hypoxia signaling to genes: significance in Alzheimer's disease |
| Q62746751 | Identification and characterization of a new alpha-synuclein isoform and its role in Lewy body diseases |
| Q53221664 | Identification of a novel mutation (Leu282Arg) of the human presenilin 1 gene in Alzheimer's disease |
| Q38933827 | Identification of new Presenilin-1 phosphosites: implication for γ-secretase activity and Aβ production |
| Q43612082 | Inhibitory effect of a presenilin 1 mutation on the Wnt signalling pathway by enhancement of beta-catenin phosphorylation |
| Q35070055 | KIAA1462, a coronary artery disease associated gene, is a candidate gene for late onset Alzheimer disease in APOE carriers |
| Q37993591 | Lessons from genome‐wide association studies findings in Alzheimer's disease |
| Q53280423 | Linear patterns of Alzheimer's disease mutations along alpha-helices of presenilins as a tool for PS-1 model construction. |
| Q47770377 | Localization and Possible Functions of Presenilins in Brain |
| Q48330746 | Metabonomic Profiling of TASTPM Transgenic Alzheimer’s Disease Mouse Model |
| Q28114960 | Molecular enzymology of mammalian Delta1-pyrroline-5-carboxylate synthase. Alternative splice donor utilization generates isoforms with different sensitivity to ornithine inhibition |
| Q37209771 | Molecular genetics of Alzheimer's disease: an update |
| Q37462203 | Molecular pathology of Lewy body diseases. |
| Q46956274 | Nasal Colivelin treatment ameliorates memory impairment related to Alzheimer's disease |
| Q35009345 | Pharmacogenomics for the treatment of dementia |
| Q36320612 | Physiologically generated presenilin 1 lacking exon 8 fails to rescue brain PS1-/- phenotype and forms complexes with wildtype PS1 and nicastrin |
| Q33971264 | Presenilin structure, function and role in Alzheimer disease. |
| Q28137764 | Presenilins interact with armadillo proteins including neural-specific plakophilin-related protein and beta-catenin |
| Q37242236 | Presenilins: members of the gamma-secretase quartets, but part-time soloists too. |
| Q34756333 | Prioritization of candidate disease genes by topological similarity between disease and protein diffusion profiles |
| Q34997956 | Prostaglandins and other lipid mediators in Alzheimer's disease |
| Q30493863 | Protein aggregates and novel presenilin gene variants in idiopathic dilated cardiomyopathy |
| Q88913269 | Protein levels of ADAM10, BACE1, and PSEN1 in platelets and leukocytes of Alzheimer's disease patients |
| Q42525989 | Regulatory region variability in the human presenilin-2 (PSEN2) gene: potential contribution to the gene activity and risk for AD. |
| Q33688075 | Signalling through the JAK-STAT pathway in the developing brain |
| Q36197138 | Sporadic Alzheimer disease fibroblasts display an oxidative stress phenotype |
| Q27315066 | The Guinea Pig as a Model for Sporadic Alzheimer's Disease (AD): The Impact of Cholesterol Intake on Expression of AD-Related Genes |
| Q24806449 | The presenilins |
| Q31832151 | The regulation of presenilin-1 by nerve growth factor |
| Q33856418 | YAC fragmentation with repetitive and single-copy sequences: detailed physical mapping of the presenilin 1 gene on chromosome 14. |
Search more.